Foundry Partners, LLC - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 65 filers reported holding IRADIMED CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2021$2,090,000
-4.2%
62,225
-16.1%
0.08%0.0%
Q2 2021$2,181,000
-4.4%
74,170
-16.2%
0.08%0.0%
Q1 2021$2,281,000
+8.7%
88,495
-3.8%
0.08%
-8.5%
Q4 2020$2,098,000
+11.5%
92,015
+4.5%
0.08%
-9.9%
Q3 2020$1,882,000
+9.6%
88,025
+19.0%
0.09%
+8.3%
Q2 2020$1,717,00073,9900.08%
Other shareholders
IRADIMED CORP shareholders Q2 2020
NameSharesValueWeighting ↓
Nine Ten Capital Management LLC 715,877$32,100,0004.18%
Soleus Capital Management, L.P. 430,051$19,283,0002.49%
RESOURCE CONSULTING GROUP INC 128,000$5,740,0001.99%
RK Capital 213,200$9,560,0001.88%
Capital Impact Advisors, LLC 22,797$1,022,0000.74%
G2 Investment Partners Management LLC 61,326$2,750,0000.65%
EAM Investors, LLC 76,179$3,416,0000.64%
Ranger Investment Management 193,306$8,668,0000.55%
EAM Global Investors LLC 42,885$1,923,0000.36%
Hillsdale Investment Management Inc. 121,500$5,448,0000.35%
View complete list of IRADIMED CORP shareholders